ONDANSETRON Side Effects

6695893-1 | Vomiting
on May 05, 2009 Female patient from UNITED STATES , 71 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with Ondansetron (View Usage). Patient experienced the following unwanted or unexpected effects: vomiting. Ondansetron dosage: 4mg As Required.

6695885-2 | Convulsion, Foaming At Mouth, Grand Mal Convulsion
Patient was taking Ondansetron (View Usage). Patient had the following side effects: convulsion, foaming at mouth, grand mal convulsion on Feb 17, 2010 from UNITED STATES Additional patient health information: Male patient , 28 years of age, weighting 187.4 lb, was diagnosed with vomiting, sepsis (What is sepsis?), prophylaxis, deep vein thrombosis (What is deep vein thrombosis?) and. Ondansetron dosage: 10mg Single Dose. During the same period patient was treated with PRIMAXIN (1g Three Times Per Day) (View Primaxin Review and Primaxin Label ), TOBRAMYCIN (250mg Twice Per Day) (View Tobramycin Review and Tobramycin Label ), METHADONE HYDROCHLORIDE (20mg Twice Per Day) (View Methadone Hydrochloride Review and Methadone Hydrochloride Label ), CLONIDINE HYDROCHLORIDE (.3mg Per Day) (View Clonidine Hydrochloride Review and Clonidine Hydrochloride Label ), RANITIDINE (50mg Three Times Per Day) (View Ranitidine Review and Ranitidine Label ), WARFARIN SODIUM (7.5mg Per Day) (View Warfarin Sodium Review and Warfarin Sodium Label ), METOCLOPRAMIDE HYDROCHLORIDE (10mg Three Times Per Day) (View Metoclopramide Hydrochloride Review and Metoclopramide Hydrochloride Label ), ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ).

6694493-7 | Dyskinesia, Movement Disorder
Adverse event was reported on Apr 21, 2010 by a Male patient taking Ondansetron (View Usage) (Dosage: ) was diagnosed with prophylaxis of nausea and vomiting, pain (What is pain?) and. Location: , child 7 years of age, After Ondansetron was administered, patient had the following side effects: dyskinesia, movement disorder (What is movement disorder?). During the same period patient was treated with HYDROMORPHONE HCL (View Hydromorphone Hcl Review and Hydromorphone Hcl Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), GRANISETRON (View Granisetron Review and Granisetron Label ), HYDROXYZINE (50 Mg) (View Hydroxyzine Review and Hydroxyzine Label ), DIMENHYDRINATE (View Dimenhydrinate Review and Dimenhydrinate Label ), RANITIDINE (150 Mg) (View Ranitidine Review and Ranitidine Label ), BISACODYL (View Bisacodyl Review and Bisacodyl Label ). Patient was hospitalized.

6693771-5 | Aphasia, Disturbance In Attention, Serotonin Syndrome, Unresponsive To Stimuli
on Apr 06, 2010 Female patient from UNITED STATES , 44 years of age, was diagnosed with prophylaxis of nausea and vomiting, induction of anaesthesia and was treated with Ondansetron (View Usage). Patient experienced the following unwanted or unexpected effects: aphasia (What is aphasia?), disturbance in attention, serotonin syndrome, unresponsive to stimuli. Ondansetron dosage: 4 Mg Intravenous. During the same period patient was treated with FENTANYL (100 Ug And 250 Ug) (View Fentanyl Review and Fentanyl Label ), QUETIAPINE (View Quetiapine Review and Quetiapine Label ), DULOXETINE HYDROCHLORIDE (View Duloxetine Hydrochloride Review and Duloxetine Hydrochloride Label ), LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), TOPIRAMATE (View Topiramate Review and Topiramate Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ).


6693722-3 | Serotonin Syndrome
on Apr 05, 2010 Female patient from UNITED STATES , 44 years of age, was diagnosed with prophylaxis of nausea and vomiting, induction of anaesthesia and was treated with Ondansetron (View Usage). Patient had the following side effects: serotonin syndrome. Ondansetron dosage: 4 Mg Daily, Intravenous. During the same period patient was treated with QUETIAPINE (View Quetiapine Review and Quetiapine Label ), DULOXETINE HYDROCHLORIDE (View Duloxetine Hydrochloride Review and Duloxetine Hydrochloride Label ), FENTANYL 100 (100 Ug Daily, Intravenous) (View Fentanyl-100 Review and Fentanyl-100 Label ), LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), TOPIRAMATE (View Topiramate Review and Topiramate Label ), PROPOFOL (View Propofol Review and Propofol Label ).

6692371-0 | Hepatitis, Malaise
Patient was taking Ondansetron (View Usage). After Ondansetron was administered, patient had the following side effects: hepatitis (What is hepatitis?), malaise on Apr 09, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 64 years of age, . Ondansetron dosage: 8 Mg. During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), GEMCITABINE (View Gemcitabine Review and Gemcitabine Label ), METOCLOPRAMIDE (METOCLOPRAMIDE) (METOCLOPRAMIDE) (View Metoclopramide (metoclopramide) (metoclopramide) Review and Metoclopramide (metoclopramide) (metoclopramide) Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), PARACETAMOL (PARAVCETAMOL) (PARACETAMIL) (View Paracetamol (paravcetamol) (paracetamil) Review and Paracetamol (paravcetamol) (paracetamil) Label ).

6689824-8 | Hepatitis, Malaise
Adverse event was reported on Apr 06, 2010 by a Female patient taking Ondansetron (View Usage) (Dosage: ) was diagnosed with non-small cell lung cancer metastatic and. Location: UNITED KINGDOM , 64 years of age, weighting 105.8 lb, Patient experienced the following unwanted or unexpected effects: hepatitis (What is hepatitis?), malaise. During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), GEMCITABINE HCL (View Gemcitabine Hcl Review and Gemcitabine Hcl Label ), METOCLOPRAMIDE HYDROCHLORIDE (View Metoclopramide Hydrochloride Review and Metoclopramide Hydrochloride Label ), IBRUPROFEN (View Ibruprofen Review and Ibruprofen Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), TRAMADOL HYDROCHLORIDE (View Tramadol Hydrochloride Review and Tramadol Hydrochloride Label ). Patient was hospitalized.

6679667-3 | Dystonia
on Apr 07, 2010 Female patient from UNITED KINGDOM , 56 years of age, was treated with Ondansetron (View Usage). Patient had the following side effects: dystonia (What is dystonia?). Ondansetron dosage: 16mg Per Day. During the same period patient was treated with METOCLOPRAMIDE HYDROCHLORIDE (30mg Per Day) (View Metoclopramide Hydrochloride Review and Metoclopramide Hydrochloride Label ). Patient was hospitalized.

6678234-5 | Abdominal Pain Upper, Constipation, Migraine, Nightmare
on Apr 08, 2010 Female patient from UNITED STATES , 37 years of age, weighting 142.0 lb, was diagnosed with nausea (What is nausea?) and was treated with Ondansetron (View Usage). After Ondansetron was administered, patient had the following side effects: abdominal pain upper, constipation (What is constipation?), migraine (What is migraine?), nightmare. Ondansetron dosage: 4 Mg Every 8 Hrs Po.

6675492-8 | Hepatitis, Malaise
Patient was taking Ondansetron (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis (What is hepatitis?), malaise on Apr 01, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 64 years of age, weighting 105.8 lb, was diagnosed with non-small cell lung cancer metastatic and. Ondansetron dosage: . During the same period patient was treated with GEMCITABINE HCL (View Gemcitabine Hcl Review and Gemcitabine Hcl Label ), METOCLOPRAMIDE HYDROCHLORIDE (View Metoclopramide Hydrochloride Review and Metoclopramide Hydrochloride Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), TRAMADOL HYDROCHLORIDE (View Tramadol Hydrochloride Review and Tramadol Hydrochloride Label ), IBRUPROFEN (View Ibruprofen Review and Ibruprofen Label ). Patient was hospitalized.

6673142-8 | Aphasia, Disturbance In Attention, Serotonin Syndrome, Unresponsive To Stimuli
Adverse event was reported on Apr 06, 2010 by a Female patient taking Ondansetron (View Usage) (Dosage: 4 Mg, One Dose; Iv) was diagnosed with prophylaxis of nausea and vomiting and. Location: UNITED STATES , 44 years of age, Patient had the following side effects: aphasia (What is aphasia?), disturbance in attention, serotonin syndrome, unresponsive to stimuli. During the same period patient was treated with DULOXETINE HYDROCHLORIDE (View Duloxetine Hydrochloride Review and Duloxetine Hydrochloride Label ), FENTANYL (100, 250 Ug, Pre And Peri-operatively; Intravenous) (View Fentanyl Review and Fentanyl Label ), LITHIUM (View Lithium Review and Lithium Label ), QUETIAPINE (View Quetiapine Review and Quetiapine Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), TOPIRAMATE (View Topiramate Review and Topiramate Label ). Patient was hospitalized.

6672792-2 | Arrhythmia, Atrial Fibrillation, Atrioventricular Block Second Degree, Body Temperature Increased, Decreased Appetite, Electrocardiogram Qt Prolonged, Gastritis, Heart Rate Decreased, Hiatus Hernia
on Mar 22, 2010 Female patient from UNITED STATES , 46 years of age, was diagnosed with nausea (What is nausea?) and was treated with Ondansetron (View Usage). After Ondansetron was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), atrial fibrillation (What is atrial fibrillation?), atrioventricular block second degree, body temperature increased, decreased appetite, electrocardiogram qt prolonged, gastritis, heart rate decreased, hiatus hernia. Ondansetron dosage: Intravenous. During the same period patient was treated with VALSARTAN/HYDROCHLOROTHIAZIDE (View Valsartan/hydrochlorothiazide Review and Valsartan/hydrochlorothiazide Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ).

6669614-2 | Atrioventricular Block Second Degree
on Mar 23, 2010 Female patient from UNITED STATES , 46 years of age, was diagnosed with nausea (What is nausea?), hypertension, gastritis, sedation and was treated with Ondansetron (View Usage). Patient experienced the following unwanted or unexpected effects: atrioventricular block second degree. Ondansetron dosage: . During the same period patient was treated with DIOVAN HCT (View Diovan Hct Review and Diovan Hct Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ). Patient was hospitalized.

6664758-3 | Ascites, Constipation, Metastases To Gastrointestinal Tract, Small Intestinal Perforation
Patient was taking Ondansetron (View Usage). Patient had the following side effects: ascites, constipation (What is constipation?), metastases to gastrointestinal tract, small intestinal perforation on Mar 15, 2010 from Additional patient health information: Female patient , 50 years of age, was diagnosed with pancreatic carcinoma and. Ondansetron dosage: Oral. During the same period patient was treated with GEMCITABINE HCL (1000mg/m2, Every 3w/4; Iv) (View Gemcitabine Hcl Review and Gemcitabine Hcl Label ). Patient was hospitalized.

6659922-3 | Dyskinesia, Excessive Eye Blinking, Jaw Disorder, Movement Disorder, Nervous System Disorder
Adverse event was reported on Mar 11, 2010 by a Male patient taking Ondansetron (View Usage) (Dosage: 4mg - Q8 Hours - Oral) was diagnosed with prophylaxis of nausea and vomiting and. Location: CANADA , child 7 years of age, After Ondansetron was administered, patient had the following side effects: dyskinesia, excessive eye blinking, jaw disorder, movement disorder (What is movement disorder?), nervous system disorder. During the same period patient was treated with HYDROMORPHONE HCL (View Hydromorphone Hcl Review and Hydromorphone Hcl Label ), HYDROXYZINE (View Hydroxyzine Review and Hydroxyzine Label ), DIMENHYDRINATE (View Dimenhydrinate Review and Dimenhydrinate Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), RANITIDINE HCL (View Ranitidine Hcl Review and Ranitidine Hcl Label ), BISACODYL (View Bisacodyl Review and Bisacodyl Label ), DOCUSATE (View Docusate Review and Docusate Label ). Patient was hospitalized.

6656665-7 | Atrioventricular Block Second Degree
on Mar 25, 2010 Female patient from , 46 years of age, was diagnosed with nausea (What is nausea?), sedation, gastritis, hypertension and was treated with Ondansetron (View Usage). Patient experienced the following unwanted or unexpected effects: atrioventricular block second degree. Ondansetron dosage: . During the same period patient was treated with MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), VALSARTAN/HYDROCHLOROTHIAZIDE (View Valsartan/hydrochlorothiazide Review and Valsartan/hydrochlorothiazide Label ).

6641529-5 | Urticaria
on Mar 17, 2010 Male patient from UNITED STATES , child 9 years of age, weighting 95.90 lb, was diagnosed with nausea (What is nausea?) and was treated with Ondansetron (View Usage). Patient had the following side effects: urticaria. Ondansetron dosage: 4mg Once Iv.

6600266-3 | Constipation, Ileal Perforation
Patient was taking Ondansetron (View Usage). After Ondansetron was administered, patient had the following side effects: constipation (What is constipation?), ileal perforation on Jan 25, 2010 from Additional patient health information: Female patient , 50 years of age, was diagnosed with pancreatic carcinoma and. Ondansetron dosage: Oral. During the same period patient was treated with GEMCITABINE (1000mg/m2 Every 3w/4 Iv) (View Gemcitabine Review and Gemcitabine Label ). Patient was hospitalized.

6551356-5 | Collapse Of Lung, Diaphragmatic Hernia, Diaphragmatic Rupture, Haemothorax, Infusion Site Extravasation, Infusion Site Haematoma, Peritoneal Haemorrhage, Respiratory Distress, Respiratory Failure
Adverse event was reported on Jan 05, 2010 by a Male patient taking Ondansetron (View Usage) (Dosage: ) was diagnosed with vomiting, procedural pain and. Location: , 35 years of age, Patient experienced the following unwanted or unexpected effects: collapse of lung, diaphragmatic hernia, diaphragmatic rupture, haemothorax, infusion site extravasation, infusion site haematoma, peritoneal haemorrhage, respiratory distress, respiratory failure. During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), PROCHLORPERAZINE (View Prochlorperazine Review and Prochlorperazine Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ). Patient was hospitalized.

6550066-8 | Blood Ph Decreased, Serotonin Syndrome
on Jan 08, 2010 Male patient from SPAIN , child 5 years of age, was diagnosed with vomiting and was treated with Ondansetron (View Usage). Patient had the following side effects: blood ph decreased, serotonin syndrome. Ondansetron dosage: 2 Mg X 1,.

6546027-5 | Dystonia, Tachycardia
on Jan 21, 2010 Female patient from UNITED STATES , 34 years of age, was treated with Ondansetron (View Usage). After Ondansetron was administered, patient had the following side effects: dystonia (What is dystonia?), tachycardia. Ondansetron dosage: 8 Mg Once Iv.

6545767-1 | Anxiety, Blood Pressure Decreased, Coronary Artery Disease, Coronary Ostial Stenosis, Depression, Headache, Hypokalaemia, Hypomagnesaemia
Patient was taking Ondansetron (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), blood pressure decreased, coronary artery disease (What is coronary artery disease?), coronary ostial stenosis, depression (What is depression?), headache (What is headache?), hypokalaemia, hypomagnesaemia on Jan 09, 2010 from UNITED STATES Additional patient health information: Female patient , 47 years of age, was diagnosed with nausea (What is nausea?), gastrooesophageal reflux disease, anxiety (What is anxiety?), depression (What is depression?) and. Ondansetron dosage: . During the same period patient was treated with DROPERIDOL (View Droperidol Review and Droperidol Label ), ESTROGENS (View Estrogens Review and Estrogens Label ), CIMETIDINE (Oral) (View Cimetidine Review and Cimetidine Label ), NORTRIPTYLINE HCL (View Nortriptyline Hcl Review and Nortriptyline Hcl Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ).

6545627-6 | Extrapyramidal Disorder, Neurological Symptom, Peritoneal Haemorrhage, Somatoform Disorder, Somnolence
Adverse event was reported on Jan 06, 2010 by a Female patient taking Ondansetron (View Usage) (Dosage: 4 Mg 1x, Intravenous (not Otherwise Specified)) was diagnosed with nausea (What is nausea?) and. Location: UNITED STATES , 37 years of age, Patient had the following side effects: extrapyramidal disorder, neurological symptom, peritoneal haemorrhage, somatoform disorder, somnolence. During the same period patient was treated with LIDOCAINE (View Lidocaine Review and Lidocaine Label ), THIOPENTAL SODIUM (View Thiopental Sodium Review and Thiopental Sodium Label ), SUCCINYLCHOLINE CHLORIDE (View Succinylcholine Chloride Review and Succinylcholine Chloride Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ), OXYGEN (View Oxygen Review and Oxygen Label ). Patient was hospitalized.

6545180-7 | Dysgeusia, Throat Irritation
on Jan 12, 2010 Male patient from UNITED STATES , 49 years of age, was treated with Ondansetron (View Usage). After Ondansetron was administered, patient had the following side effects: dysgeusia, throat irritation. Ondansetron dosage: 4mg, Once, Intravenous.

6542785-4 | Completed Suicide
on Jan 04, 2010 Male patient from UNITED STATES , 56 years of age, was treated with Ondansetron (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide. Ondansetron dosage: Oral. During the same period patient was treated with PHENYTOIN (Oral) (View Phenytoin Review and Phenytoin Label ), PHENOBARBITAL TAB (Oral) (View Phenobarbital Tab Review and Phenobarbital Tab Label ), QUETIAPINE (Oral) (View Quetiapine Review and Quetiapine Label ), ESCITALOPRAM (Oral) (View Escitalopram Review and Escitalopram Label ), METHYLPHENIDATE (Oral) (View Methylphenidate Review and Methylphenidate Label ).

6541191-6 | Chloroma
Patient was taking Ondansetron (View Usage). Patient had the following side effects: chloroma on Jan 13, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 62 years of age, was diagnosed with aquagenic pruritus and. Ondansetron dosage: 24mg Per Day. During the same period patient was treated with DOXEPIN HCL (100mg Per Day) (View Doxepin Hcl Review and Doxepin Hcl Label ).

6541059-5 | Abnormal Behaviour, Convulsion, Endotracheal Intubation, Hypersensitivity, Incoherent, Loss Of Consciousness, Pruritus, Rash Macular
Adverse event was reported on Jan 08, 2010 by a Male patient taking Ondansetron (View Usage) (Dosage: 4 Mg, Unk) was diagnosed with procedural nausea, anaesthesia and. Location: UNITED KINGDOM , 22 years of age, After Ondansetron was administered, patient had the following side effects: abnormal behaviour, convulsion, endotracheal intubation, hypersensitivity, incoherent, loss of consciousness, pruritus, rash macular. During the same period patient was treated with SODIUM LACTATE COMPOUND INJECTION (View Sodium Lactate Compound Injection Review and Sodium Lactate Compound Injection Label ), FENTANYL (Unk) (View Fentanyl Review and Fentanyl Label ), MORPHINE (Unk) (View Morphine Review and Morphine Label ), PROPOFOL (Unk) (View Propofol Review and Propofol Label ). Patient was hospitalized.

6537983-X | Anxiety, Dystonia, Muscle Twitching, Nausea
on Jan 04, 2010 Female patient from UNITED KINGDOM , 56 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with Ondansetron (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), dystonia (What is dystonia?), muscle twitching, nausea (What is nausea?). Ondansetron dosage: 8 Mg Bd; One Day. During the same period patient was treated with METOCLOPRAMIDE (10 Mg Tds, One Day) (View Metoclopramide Review and Metoclopramide Label ). Patient was hospitalized.

6537644-7 | Convulsion, Hypersensitivity, Loss Of Consciousness
on Jan 08, 2010 Male patient from UNITED KINGDOM , 23 years of age, was treated with Ondansetron (View Usage). Patient had the following side effects: convulsion, hypersensitivity, loss of consciousness. Ondansetron dosage: . During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ), PROPOFOL (View Propofol Review and Propofol Label ), HARTMANN'S SOLUTION (View Hartmann's Solution Review and Hartmann's Solution Label ).

6537642-3 | Convulsion, Hypersensitivity, Incoherent, Loss Of Consciousness, Pruritus, Rash Macular
Patient was taking Ondansetron (View Usage). After Ondansetron was administered, patient had the following side effects: convulsion, hypersensitivity, incoherent, loss of consciousness, pruritus, rash macular on Jan 08, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 21 years of age, . Ondansetron dosage: . During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), MORPHINE (View Morphine Review and Morphine Label ), SODIUM LACTATE IN PLASTIC CONTAINER (View Sodium Lactate In Plastic Container Review and Sodium Lactate In Plastic Container Label ). Patient was hospitalized.

6535576-1 | Hepatic Steatosis, Hepatitis Acute, Hepatitis Infectious, Hepatomegaly, Lymphopenia
Adverse event was reported on Dec 21, 2009 by a Male patient taking Ondansetron (View Usage) (Dosage: ) was diagnosed with acute lymphocytic leukaemia and. Location: UNITED STATES , child 4 years of age, Patient experienced the following unwanted or unexpected effects: hepatic steatosis, hepatitis acute, hepatitis infectious, hepatomegaly, lymphopenia. During the same period patient was treated with GRANISETRON (View Granisetron Review and Granisetron Label ), ZOSYN (View Zosyn Review and Zosyn Label ), BACTRIM (View Bactrim Review and Bactrim Label ), DAUNORUBICIN HCL (View Daunorubicin Hcl Review and Daunorubicin Hcl Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ). Patient was hospitalized.

6534610-2 | Myoclonus
on Jan 06, 2010 Male patient from UNITED KINGDOM , child 12 years of age, weighting 123.5 lb, was diagnosed with pain (What is pain?) and was treated with Ondansetron (View Usage). Patient had the following side effects: myoclonus. Ondansetron dosage: . During the same period patient was treated with ISOFLURANE (View Isoflurane Review and Isoflurane Label ), PROPOFOL (View Propofol Review and Propofol Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ), FLIXOTIDE (100mg Per Day) (View Flixotide Review and Flixotide Label ). Patient was hospitalized.

6528930-5 | Apnoea, Blood Potassium Decreased, Cardiac Arrest, Hypotension, Long Qt Syndrome, Ventricular Fibrillation
on Dec 10, 2009 Female patient from UNITED STATES , 35 years of age, was diagnosed with hypotension, anaesthesia and was treated with Ondansetron (View Usage). After Ondansetron was administered, patient had the following side effects: apnoea, blood potassium decreased, cardiac arrest (What is cardiac arrest?), hypotension, long qt syndrome, ventricular fibrillation. Ondansetron dosage: 4mg Total Dose - Iv. During the same period patient was treated with AMIODARONE HCL (300mg Total Dose - Unk) (View Amiodarone Hcl Review and Amiodarone Hcl Label ), COCAINE (250mg Total Dose - Nasal) (View Cocaine Review and Cocaine Label ), EPINEPHRINE (60mcg Total Dose- Nasal) (View Epinephrine Review and Epinephrine Label ), LIDOCAINE 2% (100mg Total Dose - Nasal) (View Lidocaine 2% Review and Lidocaine 2% Label ), OXYGEN (Unk - Unk - Unk) (View Oxygen Review and Oxygen Label ), SEVOFLURANE (Unk - Unk - Inhalation) (View Sevoflurane Review and Sevoflurane Label ), ATROPINE (View Atropine Review and Atropine Label ). Patient was hospitalized.

6525852-0 | Grand Mal Convulsion, Hypersensitivity, Incoherent, Loss Of Consciousness, Rash Macular
Patient was taking Ondansetron (View Usage). Patient experienced the following unwanted or unexpected effects: grand mal convulsion, hypersensitivity, incoherent, loss of consciousness, rash macular on Dec 23, 2009 from UNITED KINGDOM Additional patient health information: Male patient , 22 years of age, . Ondansetron dosage: . During the same period patient was treated with FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ), PROPOFOL (View Propofol Review and Propofol Label ), SODIUM LACTATE IN PLASTIC CONTAINER (View Sodium Lactate In Plastic Container Review and Sodium Lactate In Plastic Container Label ), MORPHINE (View Morphine Review and Morphine Label ).

6525719-8 | Apnoea, Loss Of Consciousness, Sinus Bradycardia
Adverse event was reported on Dec 14, 2009 by a Female patient taking Ondansetron (View Usage) (Dosage: 2 Mg (total), Intravenous) . Location: INDIA , child 8 years of age, weighting 33.00 lb, Patient had the following side effects: apnoea, loss of consciousness, sinus bradycardia.

6525709-5 | Bradycardia, Loss Of Consciousness, Respiratory Arrest
on Dec 14, 2009 Male patient from INDIA , 60 years of age, was treated with Ondansetron (View Usage). After Ondansetron was administered, patient had the following side effects: bradycardia, loss of consciousness, respiratory arrest. Ondansetron dosage: 4 Mg, Once, Intravenous. During the same period patient was treated with GLYCOPYRROLATE (View Glycopyrrolate Review and Glycopyrrolate Label ).

6523004-1 | Adenovirus Infection, Hepatic Steatosis, Hepatitis Acute, Hepatomegaly, Lymphopenia
on Dec 07, 2009 Male patient from UNITED STATES , child 4 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Ondansetron (View Usage). Patient experienced the following unwanted or unexpected effects: adenovirus infection, hepatic steatosis, hepatitis acute, hepatomegaly, lymphopenia. Ondansetron dosage: . During the same period patient was treated with GRANISETRON (View Granisetron Review and Granisetron Label ), ZOSYN (View Zosyn Review and Zosyn Label ), BACTRIM (View Bactrim Review and Bactrim Label ), DAUNORUBICIN HCL (View Daunorubicin Hcl Review and Daunorubicin Hcl Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ). Patient was hospitalized.

6522846-6 | Grand Mal Convulsion, Vomiting
Patient was taking Ondansetron (View Usage). Patient had the following side effects: grand mal convulsion, vomiting on Dec 16, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 53 years of age, weighting 154.0 lb, . Ondansetron dosage: .

6520745-7 | Abnormal Behaviour, Convulsion, Endotracheal Intubation, Hypersensitivity, Incoherent, Loss Of Consciousness, Pruritus, Rash Macular
Adverse event was reported on Dec 23, 2009 by a Male patient taking Ondansetron (View Usage) (Dosage: 4 Mg, Unk) was diagnosed with procedural nausea, anaesthesia and. Location: UNITED KINGDOM , 22 years of age, After Ondansetron was administered, patient had the following side effects: abnormal behaviour, convulsion, endotracheal intubation, hypersensitivity, incoherent, loss of consciousness, pruritus, rash macular. During the same period patient was treated with SODIUM LACTATE COMPOUND INJECTION (View Sodium Lactate Compound Injection Review and Sodium Lactate Compound Injection Label ), FENTANYL 100 (Unk) (View Fentanyl-100 Review and Fentanyl-100 Label ), MORPHINE (View Morphine Review and Morphine Label ), PROPOFOL (Unk) (View Propofol Review and Propofol Label ). Patient was hospitalized.

6516423-0 | Grand Mal Convulsion, Vomiting
on Dec 16, 2009 Female patient from UNITED KINGDOM , 53 years of age, weighting 154.0 lb, was treated with Ondansetron (View Usage). Patient experienced the following unwanted or unexpected effects: grand mal convulsion, vomiting. Ondansetron dosage: .

6516175-4 | Myoclonus
on Dec 14, 2009 Male patient from UNITED KINGDOM , child 12 years of age, weighting 123.5 lb, was diagnosed with procedural nausea and was treated with Ondansetron (View Usage). Patient had the following side effects: myoclonus. Ondansetron dosage: . Patient was hospitalized.

6515077-7 | Grand Mal Convulsion, Vomiting
Patient was taking Ondansetron (View Usage). After Ondansetron was administered, patient had the following side effects: grand mal convulsion, vomiting on Dec 16, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 53 years of age, weighting 154.0 lb, . Ondansetron dosage: .

6504755-1 | Myoclonus
Adverse event was reported on Dec 03, 2009 by a Male patient taking Ondansetron (View Usage) (Dosage: 4 Mg, Intravenous) was diagnosed with procedural nausea and. Location: UNITED KINGDOM , child 12 years of age, weighting 123.5 lb, Patient experienced the following unwanted or unexpected effects: myoclonus. During the same period patient was treated with (FLIXOTIDE) (View (flixotide) Review and (flixotide) Label ), ISOFLURANE (View Isoflurane Review and Isoflurane Label ), (LIGNOCAINE /00033401/) (View (lignocaine /00033401/) Review and (lignocaine /00033401/) Label ), PROPOFOL (View Propofol Review and Propofol Label ). Patient was hospitalized.

6491189-1 | Bradycardia, Heart Rate Decreased, Loss Of Consciousness, Respiratory Arrest
on Nov 19, 2009 Male patient from INDIA , 60 years of age, was treated with Ondansetron (View Usage). Patient had the following side effects: bradycardia, heart rate decreased, loss of consciousness, respiratory arrest. Ondansetron dosage: 4 Mg, Once, Intravenous. During the same period patient was treated with GLYCOPYRROLATE (View Glycopyrrolate Review and Glycopyrrolate Label ).

6489125-7 | Apnoea, Loss Of Consciousness, Sinus Bradycardia
on Nov 19, 2009 Female patient from INDIA , weighting 33.07 lb, was treated with Ondansetron (View Usage). After Ondansetron was administered, patient had the following side effects: apnoea, loss of consciousness, sinus bradycardia. Ondansetron dosage: 2 Mg, Once, Intravenous.

6479841-5 | Dyskinesia, Muscle Spasms, Post Procedural Complication
Patient was taking Ondansetron (View Usage). Patient experienced the following unwanted or unexpected effects: dyskinesia, muscle spasms, post procedural complication on Nov 17, 2009 from Additional patient health information: Female patient , 30 years of age, . Ondansetron dosage: 4mg One Time, Iv. During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), ATRACURIUM BESYLATE (View Atracurium Besylate Review and Atracurium Besylate Label ), CEFUROXIME (View Cefuroxime Review and Cefuroxime Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), PROPOFOL (View Propofol Review and Propofol Label ), REMIFENTANIL (View Remifentanil Review and Remifentanil Label ). Patient was hospitalized.

6478364-7 | Myoclonus
Adverse event was reported on Dec 02, 2009 by a Male patient taking Ondansetron (View Usage) (Dosage: ) was diagnosed with procedural nausea and. Location: UNITED KINGDOM , child 12 years of age, weighting 123.5 lb, Patient had the following side effects: myoclonus. Patient was hospitalized.

6476955-0 | Convulsion, Hemiparesis, Retinal Haemorrhage, Subdural Haemorrhage, Venous Thrombosis
on Dec 04, 2009 Male patient from UNITED STATES , weighting 22.00 lb, was diagnosed with pyrexia, viral infection (What is viral infection?), vomiting and was treated with Ondansetron (View Usage). After Ondansetron was administered, patient had the following side effects: convulsion, hemiparesis, retinal haemorrhage, subdural haemorrhage, venous thrombosis. Ondansetron dosage: Apply Full Syringe Every Six Hours Told To Rub It On. During the same period patient was treated with MOTRIN (View Motrin Review and Motrin Label ), TYLENOL (CAPLET) (View Tylenol (caplet) Review and Tylenol (caplet) Label ). Patient was hospitalized and became disabled.

6465643-2 | Heart Rate Decreased, Loss Of Consciousness, Respiratory Arrest
on Nov 09, 2009 Male patient from INDIA , 60 years of age, was diagnosed with preoperative care and was treated with Ondansetron (View Usage). Patient experienced the following unwanted or unexpected effects: heart rate decreased, loss of consciousness, respiratory arrest. Ondansetron dosage: 4mg, Once, Iv. During the same period patient was treated with GLYCOPYRROLATE (10mcg/kg, Once) (View Glycopyrrolate Review and Glycopyrrolate Label ). Patient was hospitalized.

6465641-9 | Apnoea, Bradycardia, Loss Of Consciousness
Patient was taking Ondansetron (View Usage). Patient had the following side effects: apnoea, bradycardia, loss of consciousness on Nov 24, 2009 from Additional patient health information: Female patient , child 8 years of age, weighting 33.07 lb, . Ondansetron dosage: 2 Mg - Intravenous.